NHS launches groundbreaking sickle cell gene therapy
By Lee Peart 31 January 2025
A groundbreaking gene editing treatment is being offered to patients with sickle cell disease from today.
Assistant Director of Family Services & Strategic Partnerships
£97,632 - £108,033
North Northamptonshire£97,632 - £108,033
Assistant Director – Education, SEND and Inclusion
£97,632 - £108,033
North Northamptonshire£97,632 - £108,033
Director of Public Health
£123,000 - £139,000 plus up to £10,000 relocation expenses
Brighton, East Sussex£123,000 - £139,000 plus up to £10,000 relocation expenses
Most Read News
- Nuffield Health sells back lease on Barts hospital site
- BREAKING NEWS: BMA dismisses Streeting's fresh offer to resident doctors
- NHS fears 'one of toughest winters' as flu cases triple
- Additional £2.4n funding secured for delayed NHP scheme
- NHS rolls out remote monitoring and self-reporting tools across 12 areas
Assistant Director of Family Services & Strategic Partnerships
£97,632 - £108,033
North Northamptonshire£97,632 - £108,033
Assistant Director – Education, SEND and Inclusion
£97,632 - £108,033
North Northamptonshire£97,632 - £108,033
Director of Public Health
£123,000 - £139,000 plus up to £10,000 relocation expenses
Brighton, East Sussex£123,000 - £139,000 plus up to £10,000 relocation expenses
Most Read News
- Nuffield Health sells back lease on Barts hospital site
- BREAKING NEWS: BMA dismisses Streeting's fresh offer to resident doctors
- NHS fears 'one of toughest winters' as flu cases triple
- Additional £2.4n funding secured for delayed NHP scheme
- NHS rolls out remote monitoring and self-reporting tools across 12 areas
©2024 Hemming Group Limited. Registered in England and Wales. Registered No: 490200. VAT number GB342 023 408
